National Atomic Company Kazatomprom JSC
Consolidated Financial Statements
for the year ended 31 December 2024 and
Independent Auditor’s Report
Content
INDEPENDENT AUDITOR’S REPORT
CONSOLIDATED FINANCIAL STATEMENTS
Consolidated Statement of Profit or Loss and Other Comprehensive Income ............................................................... 1
Consolidated Statement of Financial Position ............................................................................................................. 2-3
Consolidated Statement of Cash Flows ...................................................................................................................... 4-5
Consolidated Statement of Changes in Equity ............................................................................................................... 6
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
1 NAC Kazatomprom JSC and its operations ........................................................................................................ 7
2 Economic environment of the Group .................................................................................................................. 8
3 Basis of preparation ............................................................................................................................................ 9
4 Adoption of new or revised standards and interpretations ................................................................................ 10
5 Segment information ........................................................................................................................................ 11
6 Balances and transactions with related parties ................................................................................................. 15
7 Revenue ........................................................................................................................................................... 17
8 Cost of sales ..................................................................................................................................................... 19
9 Distribution expenses ....................................................................................................................................... 19
10 General and administrative expenses .............................................................................................................. 20
11 Net (impairment losses)/reversal of impairment losses on financial assets ...................................................... 20
12 Other income .................................................................................................................................................... 20
13 Other expenses and net foreign exchange (loss)/gain ..................................................................................... 21
14 Payroll costs ..................................................................................................................................................... 21
15 Finance income and costs ................................................................................................................................ 22
16 Income tax expense ......................................................................................................................................... 22
17 Earnings per share ........................................................................................................................................... 25
18 Intangible assets ............................................................................................................................................... 26
19 Property, plant and equipment .......................................................................................................................... 27
20 Mine development assets ................................................................................................................................. 29
21 Mineral rights .................................................................................................................................................... 30
22 Exploration and evaluation assets .................................................................................................................... 31
23 Investments in associates................................................................................................................................. 32
24 Investments in joint ventures ............................................................................................................................ 35
25 Accounts receivable ......................................................................................................................................... 37
26 Other financial assets ....................................................................................................................................... 37
27 Other non-financial assets ................................................................................................................................ 39
28 Inventories ........................................................................................................................................................ 39
29 Cash and cash equivalents............................................................................................................................... 40
30 Share capital ..................................................................................................................................................... 41
31 Loans and borrowings ...................................................................................................................................... 41
32 Provisions ......................................................................................................................................................... 44
33 Accounts payable ............................................................................................................................................. 47
34 Other liabilities .................................................................................................................................................. 47
35 Contingencies and commitments ...................................................................................................................... 48
36 Non-controlling interest ..................................................................................................................................... 49
37 Principal subsidiaries ........................................................................................................................................ 53
38 Financial risk management ............................................................................................................................... 54
39 Fair value disclosures ....................................................................................................................................... 61
40 Presentation of financial instruments by measurement category ...................................................................... 62
41 Business combination ....................................................................................................................................... 62
42 Events after the reporting period ...................................................................................................................... 65